Quarterly Updates14 Nov 2025, 05:02 pm
Vivo Bio Tech Ltd Reports Q2 and H1 2025 Financial Results with a 5.6% YoY Revenue Growth
AI Summary
Vivo Bio Tech Ltd has announced its financial results for the quarter and half-year ended September 30, 2025. The company's revenue from operations for Q2 2025 stood at INR 1,301.6 crores, representing a 5.6% year-over-year growth compared to Q2 2024. The total income for H1 2025 was INR 2,681.26 crores, a 19.1% increase from H1 2024. The net profit after tax for Q2 2025 was INR 757.0 crores, and the earnings per equity share (EPS) for the quarter were INR 3.62 (basic) and INR 1.14 (diluted). The company's total assets stood at INR 15,571.85 crores as of September 30, 2025.
Key Highlights
- Revenue from operations for Q2 2025 stood at INR 1,301.6 crores, a 5.6% YoY growth.
- Total income for H1 2025 was INR 2,681.26 crores, a 19.1% increase from H1 2024.
- Net profit after tax for Q2 2025 was INR 757.0 crores.
- Earnings per equity share (EPS) for Q2 2025 were INR 3.62 (basic) and INR 1.14 (diluted).
- Total assets stood at INR 15,571.85 crores as of September 30, 2025.